Pfizer (PFE)
In a report issued on June 23, Asad Haider from Goldman Sachs maintained a Hold rating on Pfizer, with a price target of $26.00. The company’s shares closed last Friday at $24.12.
According to TipRanks.com, Haider is a 4-star analyst with an average return of 20.0% and a 83.3% success rate. Haider covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Bristol-Myers Squibb, and Johnson & Johnson.
The word on The Street in general, suggests a Hold analyst consensus rating for Pfizer with a $28.83 average price target, representing a 21.4% upside. In a report issued on June 9, RBC Capital also upgraded the stock to Hold with a $25.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
